Emilie CHALAYER, MD
CHU de Saint-Etienne · Centre Hospitalier Universitaire de Saint Etienne
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Emilie CHALAYER, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:44 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07612787 · A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple MyelomaCentre Hospitalier Universitaire de Saint Etienne · not yet recruiting · Myeloma Multiple · principal investigator
- Ph4NCT06706102 · Temporal Characterization of Extracellular Vesicles During Cellular Therapy Using CAR-T Cells and During the Occurrence of Immune Effector Cell-Associated Neurotoxicity SyndromeCentre Hospitalier Universitaire de Saint Etienne · recruiting · Immune Effector Cell Associated Neurotoxicity Syndrome · principal investigator
- N/ANCT06474182 · Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple MyelomaCentre Hospitalier Universitaire de Saint Etienne · recruiting · Multiple Myeloma, Total Knee Replacement · principal investigator
- N/ANCT05259553 · Biomarkers in Multiple MyelomaCentre Hospitalier Universitaire de Saint Etienne · active not recruiting · Hematological Patients, Newly Diagnosed Multiple Myeloma, Chemotherapy · principal investigator
- Ph2NCT05091684 · Administration of Fibrinogen Concentrate for Refractory BleedingCentre Hospitalier Universitaire de Saint Etienne · terminated · Hematological Patients, Bleeding, Platelet Refractoriness · principal investigator
- Ph2NCT03801122 · Evolution of Thromboelastography During Tranexamic Acid TreatmentCentre Hospitalier Universitaire de Saint Etienne · completed · Hematological Malignancies Treated With Intensive Chemotherapy · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.